Report cover image

Cholera Vaccines Market Growth, Size, Trends Analysis - By Type, By Product, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Feb 12, 2025
Length 228 Pages
SKU # SPER19805277

Description

Cholera Vaccines Market Introduction and Overview

According to SPER market research, ‘Global Cholera Vaccines Market Size- By Type, By Product, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Cholera Vaccines Market is predicted to reach 222.23 million by 2034 with a CAGR of 8.63%.

Cholera vaccines are biological preparations that give active immunity to cholera, an acute diarrheal disease caused by the bacterium Vibrio cholerae. These vaccinations are intended to boost the immune system in order to prevent the disease from developing after exposure to the pathogen. Furthermore, increased travel to endemic areas drives up demand for cholera vaccines, as does the development of more accessible and cheap travel vaccine formulations, which improves immunization efforts and market penetration.

Restraints: Vaccine development takes a long time, and tight regulatory clearances are expected to limit market growth throughout the projection period. Vaccine manufacture is time-consuming and costly. Furthermore, cholera vaccines may have adverse impacts on human health. Regulatory clearance for individual vaccines take a lengthy time. These considerations are predicted to limit the market for cholera vaccines in the coming years.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Type, By Product, By Distribution Channel.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Valneva SE, Sanofi S.A, Astellas Pharma, Inc, Emergent BioSolutions Inc, PavVax Inc, EuBiologics Co., Ltd, Shantha Biotechnics Limited, Hilleman Laboratories, Astellas Pharma Inc, Incepta Vaccine Ltd, Vabiotech. and others.

Cholera Vaccines Market Segmentation:

By Type: Based on the Type, Global Cholera Vaccines Market is segmented as; Whole Cell v. Cholerae O1 with Recombinant B- subunit, Killed Oral O1 and O139.

By Product: Based on the Product, Global Cholera Vaccines Market is segmented as; Vaxchora, Dukoral, Shanchol, Other products.

By Distribution Channel: Based on the Distribution Channel, Global Cholera Vaccines Market is segmented as; Hospital Pharmacy, Retail Pharmacy, Other.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

228 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Cholera Vaccines Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cholera Vaccines Market
7. Global Cholera Vaccines Market, By Type (USD Million) 2021-2034
7.1. Whole Cell v. Cholerae O1 with Recombinant B- subunit
7.2. Killed Oral O1 and O139
8. Global Cholera Vaccines Market, By Product (USD Million) 2021-2034
8.1. Vaxchora
8.2. Dukoral
8.3. Shanchol
8.4. Other products
9. Global Cholera Vaccines Market, By Distribution Channel (USD Million) 2021-2034
9.1. Hospital Pharmacy
9.2. Retail Pharmacy
9.3. Other
10. Global Cholera Vaccines Market, (USD Million) 2021-2034
10.1. Global Cholera Vaccines Market Size and Market Share
11. Global Cholera Vaccines Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Valneva SE
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Sanofi S. A
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Emergent BioSolutions Inc
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. PaxVax Inc
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. EuBiologics Co., Ltd
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Shantha Biotechnics Limited
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Hilleman Laboratories
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Astellas Pharma Inc
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Incepta Vaccine Ltd
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Vabiotech
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us